The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19

Historically, federal and state policies have narrowly defined treatment models that have resulted in limited access to and engagement in counseling for individuals receiving medications for opioid use disorder (MOUD; e.g., methadone and buprenorphine). In response to the coronavirus pandemic, outpatient MOUD treatment providers rapidly transitioned from traditional, in-person care delivery models to revised COVID-19 protocols that prioritized telehealth counseling to protect the health of patients and staff and ensure continuity in MOUD care.

Source: Journal of Substance Abuse Treatment - October 8, 2020 Category: Addiction Authors: Jaclyn M.W. Hughto, Lisa Peterson, Nicholas S. Perry, Alex Donoyan, Matthew J. Mimiaga, Kimberly M. Nelson, David W. Pantalone Source Type: research